uniQure (QURE) Presents Data on Successful Readministration of Gene Therapy in Non-Human Primates – StreetInsider.com
|
uniQure (QURE) Presents Data on Successful Readministration of Gene Therapy in Non-Human Primates
StreetInsider.com uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today presented data on successful repeated hepatic gene delivery with uniQure's AAV5 vector following a … |
